Previous studies have identified CHD5[9] and KIF1B[10] as candidate tumor suppressor genes in this region, and more recently it was reported that disruption of PER3 function may indicate the likelihood of tumor recurrence in patients with ERα-positive tumors[11]. This evidence concerns the gene CHD5 and neoplasm.